Finally, the ESRD CPM Project focuses on intermediate outcomes of anemia management, vascular access, dialysis adequacy, and serum albumin and does not collect data on the more firm clinical outcomes of neurocognitive development, hospitalization, or mortality. The gene discussed is ALB; the disease is anemia.